1997
DOI: 10.1055/s-0038-1657722
|View full text |Cite
|
Sign up to set email alerts
|

An in vivo Model for the Assessment of Acute Fibrinolytic Capacity of the Endothelium

Abstract: SummaryThe effects on blood flow and plasma fibrinolytic and coagulation parameters of intraarterial substance P, an endothelium dependent vasodilator, and sodium nitroprusside, a control endothelium independent vasodilator, were studied in the human forearm circulation. At subsystemic locally active doses, both substance P (2-8 pmol/min) and sodium nitroprusside (2-8 μg/min) caused dose-dependent vasodilatation (p <0.001 for both) without affecting plasma concentrations of PAI-1, von Willebrand factor anti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
112
0

Year Published

2000
2000
2011
2011

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 84 publications
(117 citation statements)
references
References 18 publications
5
112
0
Order By: Relevance
“…First, in this and previous studies, it has been consistently demonstrated that SNP does not induce tPA release at doses that increase FBF and shear stress. 6,21,22 Second, treatment with L-NMMA and indomethacin selectively modulated vasodilation without altering the tPA response to BK. Regardless, the finding that B 2 receptor antagonism blocks the effects of exogenous BK on tPA release from the human vasculature lays the groundwork for studies elucidating the contribution of endogenous BK to the effects of ACE inhibitors on endothelial tPA release in humans.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…First, in this and previous studies, it has been consistently demonstrated that SNP does not induce tPA release at doses that increase FBF and shear stress. 6,21,22 Second, treatment with L-NMMA and indomethacin selectively modulated vasodilation without altering the tPA response to BK. Regardless, the finding that B 2 receptor antagonism blocks the effects of exogenous BK on tPA release from the human vasculature lays the groundwork for studies elucidating the contribution of endogenous BK to the effects of ACE inhibitors on endothelial tPA release in humans.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, an NO-independent effect of BK on tPA release is further supported by the finding in this and numerous other studies that SNP, an NO donor, does not stimulate endothelial tPA release. 6,21,22 Studies in vitro and in vivo suggest that prostaglandins do not contribute significantly to the vasodilator response to BK in human vasculature. Thus, pretreatment with COX inhibitors such as aspirin or indomethacin does not alter vasodilation to BK in isolated coronary or resistance arteries.…”
Section: Discussionmentioning
confidence: 99%
“…2 This has allowed us to show that cigarette smoking is associated with an impairment of acute tPA release in the forearm circulation. 6 We hypothesized that the acute local coronary release of tPA would be influenced by both the extent of coronary atheroma and smoking habit.…”
mentioning
confidence: 98%
“…This dynamic aspect of endothelial function and fibrinolytic balance may be directly relevant to the pathogenesis of atherothrombosis, but only recently have robust methods to determine acute tPA release been developed. 2 Small areas of denudation and thrombus deposition are a common finding on the surface of atheromatous plaques and are usually subclinical. 3 In the presence of an imbalance in the fibrinolytic system, however, such microthrombi may propagate, ultimately leading to arterial occlusion.…”
mentioning
confidence: 99%
“…82 In this model, different stimuli, such as desmopressin 83 or bradykinin, 84 are used to stimulate endothelial cells to release t-PA. To avoid confounding hemodynamic effects related to the systemic infusion, as well as the activation of the sympathetic nervous system and concomitant release of other mediators, investigators have primarily focused on the measurement of the t-PA release in individual vascular beds. Regional forearm t-PA release in response to intrabrachial infusions has been assessed by using 2 similar methodologies: the arteriovenous technique, 85 based on the differences in plasma concentrations of t-PA between the inflowing arterial and outflowing venous plasma of a single arm, and the venovenous technique, 86 based on the differences in venous plasma concentrations between the 2 arms. Both methods use strain gauge plethysmography to measure forearm blood flow which, multiplied by the difference in the t-PA measured and corrected for hematocrit, gives the net t-PA release in the forearm.…”
Section: Markers Of Thrombosismentioning
confidence: 99%